4
Changes in Ownership
Yarrow Bioscience, Inc. Filed Acc 0001209191-20-053159
Chief Commercial Officer gave up 1,541 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Wiley Matthew T. · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-09-30 | Shares withheld for taxes : show line 1 in the form | −1,541 | $1.66 | $2,558 | 350,884 | D |
Loading xslF345X03/doc4.xml…